https://www.selleckchem.com/btk.html This combination was suitable for the normalisation of mRNA expression in placentas supplying GD30, 60 and 90 foetuses of different size. This study has identified reference genes with stable expression in placentae and endometria across multiple gestational days, in tissues associated with foetuses of different size and sex. The results of these experiments highlight the importance of selecting appropriate reference genes for the biological comparison under investigation. This article is protected by copyright. All rights reserved.We have previously demonstrated a distinct hepatic miRNA signature (downregulation of miRNA-23a, -150, - 200b, -503, -663 and upregulation of miRNA-20a) is associated with successful regeneration in auxiliary liver transplantation (ALT). This study aimed to evaluate whether the serum expression of this regeneration-linked miRNA signature is associated with clinical outcomes in acute and chronic liver disease. These were represented by patients with acetaminophen (APAP) induced acute liver failure (ALF) (n=18) and patients with hepatitis C (HCV) undergoing treatment with direct-acting antivirals (DAA) (n=56) respectively. Patients were grouped depending on their clinical outcome. Global serum miRNA expression was analysed using PCR-arrays and selected miRNA expression using targeted PCR. We demonstrate that specific regeneration-linked miRNAs discriminate outcomes in both clinical scenarios. We further show that miRNA-20a, -23a, -150, -200b, -503 and -663 undergo concordant changes in expression in 3 distinct clinical settings, liver regeneration accompanying successful ALT, clinical recovery after ALF, and clinical recompensation after cure of HCV. This miRNA signature represents a potentially novel biomarker to predict outcome and optimise patient selection for liver transplantation in both acute and chronic liver disease. This article is protected by copyright. All rights reserved.Cyclic RGD peptides